Recurrent Urinary Tract Infections Clinical Trials
3 recruiting trials for Recurrent Urinary Tract Infections. Eligibility criteria explained in plain English.
TrialFinderData lists 3 Recurrent Urinary Tract Infections clinical trials drawn from ClinicalTrials.gov, all of which are currently recruiting participants.
Research is led by University of Texas Southwestern Medical Center (1), Odense University Hospital (1), Jahn Ferenc South Pest Teaching Hospital (1), among the most active sponsors registered for these trials.
The most frequently studied intervention is D-Mannose (dietary_supplement, 1 trial), followed by Placebo, ABU bladder lavage.
Track Recurrent Urinary Tract Infections trials
Subscribe for TrialFinderData updates by email. No spam, unsubscribe anytime.
Recruiting Trials
Clinical trial data sourced from the ClinicalTrials.gov registry, maintained by the National Library of Medicine. Always consult your doctor before considering any clinical trial.
A Trial of D-mannose for the Prophylaxis of Recurrent Urinary Tract Infections
A randomized, double-blind, placebo-controlled, 12-month study to determine the effectiveness of D-mannose (2g daily) supplementation in rUTI (recurrent urinary tract infection)...
Bacterial Interference for Preventing Recurrent Urinary Tract Infection - New Ways of Treatment
Urinary tract infection (UTI) is one of the most common bacterial infections worldwide. It affects 150 million people annually. Treatment of patients with UTI entails a high...
Evaluating the Efficacy and Patient Experience of Catheter-Free Intravesical Instillation
This study aims to evaluate a catheter-free method for delivering medications directly into the bladder, known as intravesical instillation, which is commonly used to treat...
Explore Other Conditions
Frequently Asked Questions
There are currently 3 clinical trials for Recurrent Urinary Tract Infections, with 3 actively recruiting participants. These include trials across all phases from early-stage Phase 1 to late-stage Phase 3.
To join a clinical trial for Recurrent Urinary Tract Infections, review the eligibility criteria on the trial detail pages, then talk to your doctor about whether a trial is right for you. Your doctor can help you evaluate the potential benefits and risks.
Phase 3 trials are large-scale studies that test whether a treatment is effective and monitor side effects. There are 0 Phase 3 trials for Recurrent Urinary Tract Infections, representing treatments closest to potential FDA approval.
Clinical trials follow strict safety protocols overseen by Institutional Review Boards (IRBs) and the FDA. Participants are monitored closely and can withdraw at any time. Always discuss risks and benefits with your healthcare provider before enrolling.
Trial data sourced from the ClinicalTrials.gov API. This site does not provide medical advice, always talk to your doctor about clinical trial participation.